Oct 8 (Reuters) - Lipocine Inc :
* LIPOCINE ANNOUNCES SUPPLY AND DISTRIBUTION AGREEMENT WITH PHARMALINK TO COMMERCIALIZE TLANDO® IN THE GULF COOPERATION COUNCIL $(GCC)$ COUNTRIES
* LIPOCINE INC - RECEIVES UPFRONT PAYMENT FROM PHARMALINK UNDER AGREEMENT TERMS
* LIPOCINE INC - PHARMALINK TO HAVE EXCLUSIVE RIGHTS TO TLANDO IN GCC REGION
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.